Skip to main content

CBIZ, Inc.

For the period ended Sep 30, 2026. Filed Oct 30, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Oct 30, 2026

CBZ$54.980.0%Stored close · as of Oct 30, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Notes to the Condensed Consolidated Financial Statements (Unaudited)

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Selected Terms Used in Notes to the Condensed Consolidated Financial Statements

ASA – Administrative Service Agreement

ASC – Accounting Standards Codification

ASU – Accounting Standards Update

CPA firm – Certified Public Accounting firm

FASB – The Financial Accounting Standards Board

GAAP – United States Generally Accepted Accounting Principles

SOFR – Secured Overnight Financing Rate

SEC – United States Securities and Exchange Commission

Merger Agreement - On July 28, 2026, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, Viking ParentCo, Inc., a Delaware corporation (“Parent”), and Viking MergerCo, Inc., a Delaware corporation and a direct wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which, upon the terms and subject to the conditions set forth therein, Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the proposed Merger as a direct wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, upon the consummation of the proposed Merger transaction, each share of common stock, par value $0.01 per share, of the Company (the “Shares” and each a “Share”) issued and outstanding immediately prior to the effective time of the Merger (other than certain excluded shares as set forth in the Merger Agreement) will be converted into the right to receive $55.00 per share in cash, without interest thereon (the “Merger Consideration”). The Merger Agreement also provides for the treatment of the Company’s outstanding equity awards in accordance with its terms upon consummation of the proposed Merger. The completion of the proposed Merger is subject to customary closing conditions, including the receipt of required regulatory approvals, the absence of any law or order prohibiting the consummation of the transaction and no material adverse effect having occurred since the signing of the Merger Agreement. The Merger Agreement also contains customary representations, warranties, covenants, and termination provisions. If the Merger Agreement is consummated, we will become a privately held company and our common stock will be delisted from the New York Stock Exchange and deregistered under the Securities Exchange Act of 1934, as amended.

ESPP Error- During the quarter ended June 30, 2026, the Company discovered it inadvertently purchased and delivered up to 481,049 shares of our common stock (the “excess shares”) in excess of the number of shares available under its 2007 Employee Stock Purchase Plan (as amended from time to time, the “ESPP”) and registered pursuant to two registration statements on Form S-8. The Company determined that it has an obligation to remediate this matter, including amounts expected to be paid to eligible participants for declines in shares price for shares currently held or lost profits for shares previously if sold, related interest, and applicable employer payroll taxes. Management evaluated the error in accordance with the guidance in Staff Accounting Bulletin No. 99, Materiality, and Staff Accounting Bulletin No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements. Based on this evaluation, the Company determined, after an evaluation of both quantitative and qualitative factors, that the purchase and delivery of the excess shares did not have a material impact on the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as amended. However, as a result of the purchase and delivery of the excess shares and the associated obligation, the Company revised the previously issued interim financial information for the three months ended March 31, 2026.

Marcum Transaction – On November 1, 2024, the Company completed the acquisition of Marcum LLP (“Marcum”), an accounting and advisory services firm headquartered in New York City with offices in major markets throughout the United States, to expand the breadth and depth of the Company’s professional services portfolio in the U.S. Pursuant to the Agreement and Plan of Merger dated July 30, 2024 (the “Marcum Merger Agreement”), a wholly owned subsidiary of the Company, merged with and into Marcum Advisory Group, a wholly owned subsidiary of Marcum (“MAG”), to which Marcum contributed substantially all of itsnon-attest business assets and liabilities, (the “Merger”), resulting in MAG surviving the Merger and becoming a wholly owned subsidiary of the Company. In a separate transaction, CBIZ CPAs P.C., with which the Company has an existing ASA, purchased from Marcum substantially all of Marcum’s attest business assets, subject to certain exclusions (the “Attest Purchase”). As noted in Note 1, Basis of Presentation and Significant Accounting Policies included in our Annual Report on Form 10-K for the year ended December 31, 2025, as amended, the Company does not consolidate certain CPA firms with whom we maintain ASAs, including CBIZ CPAs P.C., therefore, the Merger solely is referred to herein as the “Marcum Transaction.”

Description of Business: CBIZ, Inc. is a leading professional services advisor to middle-market businesses nationwide. With industry knowledge and expertise in accounting, tax, advisory, benefits, insurance, and technology, CBIZ delivers actionable insights to help clients anticipate what is next and discover new ways to accelerate growth to clients throughout the United States and parts of Canada. Acting through its subsidiaries, it serves small andmedium-sized businesses, as well as individuals, governmental entities, andnot-for-profit enterprises. CBIZ manages and reports its operations alongtwo practice groups: Financial Services Group and Benefits and Insurance Services Group. A further description of products and services offered by each of the practice groups is provided in Note 14, Segment Disclosures.

Basis of Consolidation: The accompanying unaudited condensed consolidated financial statements include the operations of CBIZ, Inc. and all of its wholly-owned subsidiaries after elimination of all intercompany balances and transactions. We have determined that our relationship with certain CPA firms with which we maintain ASAs qualify as variable interest entities (“VIEs”), and we are the primary beneficiary of such VIEs. The accompanying unaudited condensed consolidated financial statements do not reflect the operations or accounts of the VIEs as the impact is not material to the financial condition, results of operations, or cash flows of CBIZ.

Unaudited Interim Financial Statements: The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this Quarterly Report on Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K, as amended, for the year ended December 31, 2025.

In the opinion of CBIZ management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the full year ending December 31, 2026.

Use of Estimates: The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Changes in circumstances could cause actual results to differ materially from these estimates.

Changes in Accounting Policies: We have consistently applied the accounting policies for the periods presented as described in Note 1, Basis of Presentation and Significant Accounting Policies, to the consolidated financial statements contained in our Annual Report on Form 10-K, as amended, for the year ended December 31, 2025.

NOTE 2. NEW ACCOUNTING PRONOUNCEMENTS

Recent Accounting Pronouncements -The FASB ASC is the sole source of authoritative GAAP other than the SEC issued rules and regulations that apply only to SEC registrants. The FASB issues an ASU to communicate changes to the FASB codification. We assess and review the impact of all ASUs. ASUs not listed below were reviewed and determined to be either not applicable or are not expected to have a material impact on the consolidated financial statements.

Accounting Standard Adopted in 2026 - In July 2025, the FASB issued ASU

No. 2025-05,

Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets (“ASU

2025-05”).

This standard introduces a practical expedient for all entities when estimating expected credit losses on current accounts receivable and contract assets arising from transactions under ASC Topic 606. Under the practical expedient, entities may assume that conditions at the balance sheet date remain unchanged over the life of the asset, reducing the need to prepare complex macroeconomic forecasts for short-term balances. ASU

2025-05

is effective for public companies with annual periods beginning after December 15, 2025, and interim periods within such fiscal years, with prospective application required. We adopted ASU

2025-05

in 2026 and the adoption had no material impact on our unaudited consolidated financial statements.

NOTE 3. BUSINESS COMBINATIONS

Marcum Acquisition

Stock Consideration Transferred

Pursuant to the terms of the Marcum Transaction, with respect to the 13.6 million shares of stock consideration, approximately 9.1 million shares, in aggregate, were delivered from January 2, 2025 to September 30, 2026 to the selling shareholders. The remaining 4.5 million shares will be delivered in 15 monthly installments starting October 1, 2026.

Working Capital Adjustment Related to the Marcum Transaction

During the nine months ended September 30, 2026, the Company finalized the working capital and related purchase price adjustment associated with the Marcum Transaction in accordance with the applicable provisions of the Marcum Merger Agreement. As a result, the Company received $46.5 million in cash on January 26, 2026. In addition, the Company recorded a notes receivable of $10.7 million, of which $3.5 million was received on January 26, 2026, from Marcum and Marcum Partners SPV LLC, entities not owned by CBIZ, related to the remaining working capital payments. Total cash received from the finalization of working capital adjustment was $50.0 million during the nine months ended September 30, 2026. The Company recorded a gain of $57.2 million related to this final working capital adjustment. Additionally, the Company recorded a gain of $0.8 million associated with other acquisition related adjustments. Both gains were reported as Gain from acquisition related adjustments, net in the accompanying condensed consolidated statements of comprehensive income.

In addition to the cash received from the final working capital adjustment, the Company received $3.1 million in cash from an indemnity escrow associated with the Marcum Transaction. Total cash received on January 26, 2026 was $53.1 million.

BINDZ Acquisition

On June 1, 2026, the Company acquired BINDZ Consulting Private Limited (“BINDZ”), an India-based professional services company, for $9.8 million in cash. BINDZ previously played a critical role in supporting CBIZ’s client delivery across accounting and tax. This acquisition allows CBIZ to scale its global capabilities in India, expanding capacity for delivery of its professional services. BINDZ maintains its general ledger in local currency (or rupees). The BINDZ financials are translated into US currency, which results in foreign currency translation gain and loss.

NOTE 4. ACCOUNTS RECEIVABLE, NET

Accounts receivable, less allowance for doubtful accounts, reflects the net realizable value of receivables and approximates fair value. Unbilled revenue is recorded at estimated net realizable value. Assessing the collectability of the receivables (billed and unbilled) requires management judgment based on a combination of factors, including but not limited to, an evaluation of our historical incurred loss experience, credit-worthiness of our clients, age of the trade receivable balance, current economic conditions that may affect a client’s ability to pay, and other pertinent factors that may impact the collectivity of the receivables. Receivables arecharged-off against the allowance when the balance is deemed uncollectible.

Accounts receivable, net, at September 30, 2026 and December 31, 2025 was as follows (in thousands):

September 30, 2026December 31, 2025
Trade accounts receivable$554,320$469,209
Unbilled revenue, at net realizable value286,545136,701
Total accounts receivable840,865605,910
Allowance for doubtful accounts(58,473)(49,915)
Accounts receivable, net$782,392$555,995

Changes to the allowance for doubtful accounts for the nine months ended September 30, 2026 and year ended December 31, 2025 were as follows (in thousands):

September 30, 2026December 31, 2025
Balance at beginning of period$(49,915)$(31,715)
Provision(26,902)(34,447)
Charge-offs, net of recoveries18,34416,247
Allowance for doubtful accounts$(58,473)$(49,915)

NOTE 5. DEBT AND FINANCING ARRANGEMENTS

2024 Credit Facilities- Our primary financing arrangement is the 2024 Credit Facilities. The 2024 Credit Facilities is a $2.0 billion senior secured credit facilities, consisting of a $1.4 billion term loan (the “Term Loan”) and $600.0 million revolving credit facility (the “Revolving Credit Facility”).

The 2024 Credit Facilities matures on November 1, 2029. The Term Loan provides for scheduled annual principal amortization payments of 5% in the first two years following closing,7.5% annually in the third and fourth year following closing and 10% in the fifth year following closing, with the balance due at maturity.

The 2024 Credit Facilities contains certain restrictive covenants customary for facilities of this type, including restrictions on indebtedness, liens or other encumbrances, making certain payments, investments, or to sell or otherwise dispose of a substantial portion of assets, or to merge or consolidate with an unaffiliated entity. The 2024 Credit Facilities also limits our ability to make dividend payments. Historically, we have not paid cash dividends on our common stock. Our Board of Directors has discretion over the payment and level of dividends on our common stock, subject to the limitations of the 2024 Credit Facilities and applicable law. The 2024 Credit Facilities contains a provision that, in the event of a defined change in control, the 2024 Credit Facilities may be terminated.

In addition, the 2024 Credit Facilities includes a financial covenant requiring that Total Net Leverage Ratio not exceed 5.00 to 1.00 initially, stepping down in increments to 3.75 to 1.00 during and after the seventh fiscal quarter after the closing (with a limited ability to temporarily increase in connection with material acquisitions commencing in the sixth fiscal quarter after the closing). The 2024 Credit Facilities also requires a Minimum Consolidated Interest Coverage Ratio of 3.00 to 1.00 and affirmative and negative covenants that are in each case generally similar to those contained in our previous amended and restated 2022 credit facility, but with increases to certain baskets and caps and certain other exceptions. As of September 30, 2026, we were in compliance with all covenants under the 2024 Credit Facilities.

The balance outstanding under the 2024 Credit Facilities at September 30, 2026 and December 31, 2025 was as follows (in thousands):

September 30, 2026December 31, 2025
Short-term debt
Current portion, Term Loan$96,250$70,000
Current portion debt issuance costs, Term Loan(3,464)(3,628)
Total short-term debt$92,786$66,372
Long-term debt
Revolver Facility$176,500$142,400
Debt issuance costs, Revolver(5,224)(6,495)
Long-term portion, Term Loan1,181,2501,260,000
Long-term portion Debt Issuance Costs, Term Loan(3,778)(6,353)
Total long-term debt$1,348,748$1,389,552

The blended effective interest rates under the 2024 Credit Facilities, including the impact of interest rate swaps associated with those credit facilities, for the nine months ended September 30, 2026 and 2025 were as follows:

Nine Months Ended September 30,
20262025
Weighted average rates6.06%6.64%
Range of effective rates3.54% - 6.84%3.18% - 8.75%

We had approximately $419.8 million of available funds under the 2024 Credit Facilities at September 30, 2026, based on the terms of the commitment. Available funds under the 2024 Credit Facilities are based on a multiple of earnings before interest, taxes, depreciation and amortization as defined in the 2024 Credit Facilities, and are reduced by letters of credit, other indebtedness and outstanding borrowings under the 2024 Credit Facilities. Under the 2024 Credit Facilities, loans are charged an interest rate consisting of a base rate or term SOFR rate plus an applicable margin, letters of credit are charged based on the same applicable margin, and a commitment fee is charged on the unused portion of the 2024 Credit Facilities.

Refer to Note 10, Debt and Financing Arrangements, to the consolidated financial statements contained in our Annual Report on Form

10-K

for the year ended December 31, 2025, as amended, for further discussion on the 2024 Credit Facilities.

Other Line of Credit

  • We have an unsecured $20.0 million line of credit by and among CBIZ Benefits and Insurance, Inc. and Huntington National Bank (“line of credit”). We utilize this line of credit to support our short-term funding requirements of payroll client fund obligations due to the investment of client funds, rather than liquidating client funds that have already been invested in

available-for-sale

securities. The line of credit didnot have a balance outstanding at September 30, 2026 or December 31, 2025. The line of credit was renewed in July 2026 and will terminate on July 30, 2027.

Interest Expense

-Interest expense, including amortization of deferred financing costs, commitment fees, line of credit fees, and other applicable bank charges, for the three and nine months ended September 30, 2026 and 2025 was as follows (in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Credit facilities$23,975$27,953$72,199$80,973
Other1173810
Total$23,986$27,960$72,237$80,983

NOTE 6. COMMITMENTS AND CONTINGENCIES

Letters of Credit and Guarantees- We provide letters of credit to landlords (lessors) of our leased premises in lieu of cash security deposits, which totaled $3.2 million at both September 30, 2026 and December 31, 2025. In addition, we provide license bonds to various state agencies to meet certain licensing requirements. The amount of license bonds outstanding was $2.1 million and $2.1 million at September 30, 2026 and December 31, 2025, respectively.

Legal Proceedings- On November 10, 2023, CBIZ was named as a defendant in a putative class action lawsuit in the United States District Court for the District of Massachusetts by an individual claiming to be an employee of a CBIZ client whose personally identifiable information (“PII”) was compromised and stolen during a cyberattack CBIZ experienced on or about May 31, 2023. As a result of this incident, hackers were able to access and download certain files from CBIZ’s MOVEit Transfer server. The lawsuit alleges that CBIZ and Progress Software Corporation, the owner of MOVEit Transfer, failed to adequately secure and safeguard the individual’s, and similarly situated employees of CBIZ’s clients, PII from unauthorized access. The lawsuit seeks various remedies, including actual, compensatory, and punitive damages, along with injunctive relief, costs, and attorneys’ fees.

On December 8, 2023, CBIZ was named as a defendant in a second putative class action lawsuit in the United States District Court for the District of Massachusetts by an individual making similar claims and seeking similar remedies as in the first lawsuit regarding the cyberattack CBIZ experienced on or about May 31, 2023.

Both cases were transferred into a multidistrict litigation, styled as In Re: MOVEit Customer Data Security Breach Litigation, pending in the United States District Court for the District of Massachusetts (the “MDL”). To date, the MDL has over 300 cases against over 100 different defendants, all with claims arising out of the cyber breach by hackers of Progress Software Corporation’s MOVEit Transfer software. The MDL has a bellwether structure, under which defendants in the MDL cases have been divided into bellwether and

non-bellwether

defendants. CBIZ is a

non-bellwether

defendant. The parties to the two CBIZ MOVEit matters have reached agreement in principle to settle such matters for a combined amount of $7.2 million,

which CBIZ recorded as a loss as a component of Other income, net on the condensed consolidated statement of comprehensive income for the nine months ended September 30, 2026. CBIZ anticipates the full such amount being paid by applicable insurance coverage following approval by the MDL court of such settlement.

In June of 2025, the Company settled litigation against a small group of former employees. As part of the settlement of that litigation, the Company received a settlement payment of $12.5 million, which was recorded as a

pre-tax

gain in “Other income, net” on the Condensed Consolidated Statements of Comprehensive Income for the year ended December 31, 2025.

In addition to the items disclosed above, the Company is, from time to time, subject to claims and lawsuits arising in the ordinary course of business. We cannot predict the outcome of all such matters or estimate the possible loss, if any. Although the proceedings are subject to uncertainties in the litigation process and the ultimate disposition of these proceedings is not presently determinable, we intend to vigorously defend these matters.

Refer to Note 12, Commitments and Contingencies, to the consolidated financial statements contained in our Annual Report on Form

10-K

for the year ended December 31, 2025, as amended, for further discussion on the Company’s commitments and contingencies.

NOTE 7. FINANCIAL INSTRUMENTS

Available-For-Sale Debt Securities- In connection with certain services provided by our payroll operations, we collect funds from our clients’ accounts in advance of paying client obligations. These funds held for clients are segregated and invested in accordance with our investment policy, which requires all investments carry an investment grade rating at the time of initial investment. These investments, primarily consisting of corporate and municipal bonds, are classified asavailable-for-sale and are included in the “Funds held for clients” line item on the accompanying unaudited Condensed Consolidated Balance Sheets. The par value of these investments totaled $43.8 million and $45.0 million at September 30, 2026 and December 31, 2025, respectively, and these investments have maturity or callable dates ranging from December 2026 through March 2031.

At September 30, 2026, unrealized losses on the securities were not material and have not been recognized as a credit loss because the bonds are investment grade quality and management is not required or does not intend to sell prior to an expected recovery in value. The bond issuers continue to make timely principal and interest payments.

The following table summarizes activities related to these investments for the nine months ended September 30, 2026 and the year ended December 31, 2025 (in thousands):

Nine Months Ended September 30, 2026Year Ended December 31, 2025
Fair value at beginning of period$45,004$40,999
Purchases6,25043,375
Redemptions(1,500)(5,096)
Maturities(5,965)(34,595)
Change in bond premium2211
Fair market value adjustment(1,068)310
Fair value at end of period$42,743$45,004

In addition to the

available-for-sale

debt securities discussed above, we also held other depository assets in the amount of $0.2 million and $0.5 million at September 30, 2026 and December 31, 2025, respectively. Those depository assets are classified as Level 1 in the fair value hierarchy.

Interest Rate Swaps

  • We utilize interest rate swaps to manage interest rate risk exposure associated with our floating-rate debt under the 2024 Credit Facilities, or the forecasted acquisition of such liability. We do not purchase or hold any derivative instruments for trading or speculative purposes. Refer to Note 7, Financial Instruments, to the consolidated financial statements contained in our Annual Report on Form

10-K

for the year ended December 31, 2025, as amended, for further discussion on our interest rate swaps.

The following table summarizes our outstanding interest rate swaps and their classification in the accompanying unaudited Condensed Consolidated Balance Sheets at September 30, 2026 and December 31, 2025 (amounts in thousands, except percentages):

Notional AmountFixed RateExpirationFair ValueBalance Sheet Location
Interest rate swap$30,0001.186%12/14/2026$172Other current asset
Interest rate swap$100,0003.850%7/14/2027$390Other current asset
Interest rate swap$20,0002.450%8/14/2027$338Other current asset
Interest rate swap$25,0003.669%4/14/2028$344Other non-current asset
Interest rate swap$25,0004.488%10/14/2028$77Other non-current asset
Interest rate swap$50,0003.703%3/14/2030$1,594Other non-current asset
Interest rate swap$50,0003.503%4/14/2030$1,958Other non-current asset
Interest rate swap$50,0003.658%7/14/2030$1,814Other non-current asset
Interest rate swap$50,0003.680%7/15/2030$1,774Other non-current asset
Notional AmountFixed RateExpirationFair ValueBalance Sheet Location
Interest rate swap$100,0004.047%7/14/2026$(269)Other current liability
Interest rate swap$30,0001.186%12/14/2026$628Other current asset
Interest rate swap$100,0003.850%7/14/2027$(838)Other non-current liability
Interest rate swap$20,0002.450%8/14/2027$263Other non-current asset
Interest rate swap$25,0003.669%4/14/2028$(228)Other non-current liability
Interest rate swap$25,0004.488%10/14/2028$(805)Other non-current liability
Interest rate swap$50,0003.703%3/14/2030$(708)Other non-current liability
Interest rate swap$50,0003.503%4/14/2030$(327)Other non-current liability
Interest rate swap$50,0003.658%7/14/2030$(637)Other non-current liability
Interest rate swap$50,0003.680%7/15/2030$(681)Other non-current liability

Refer to Note

, Fair Value Measurements, for additional disclosures regarding fair value measurements.

The following table summarizes the effects of the interest rate swaps on the accompanying Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2026 and 2025 (in thousands):

Gain (Loss) Recognized in AOCI, net of tax · Gain Reclassified from AOCI into Expense
Three Months Ended September 30,Three Months Ended September 30,
2026202520262025
Interest rate swaps$4,960$(636)$161$846
Gain (Loss) Recognized in AOCI, net of tax · Gain Reclassified from AOCI into Expense
Nine Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Interest rate swaps$9,263$(3,072)$288$2,219

NOTE 8. FAIR VALUE MEASUREMENTS

The following table summarizes our assets and (liabilities) at September 30, 2026 and December 31, 2025, respectively, that are measured at fair value on a recurring basis subsequent to initial recognition and indicates the fair value hierarchy of the valuation techniques utilized by us to determine such fair value (in thousands):

LevelSeptember 30, 2026December 31, 2025
Assets of deferred compensation plan1$193,206$186,870
Other depository assets1$188$470
Deferred compensation plan obligations1$(193,206)$(186,870)
Available-for-sale debt securities2$42,743$45,004
Interest rate swaps2$8,461$(3,602)
Bank debt, net2$(1,441,534)$(1,455,924)
Contingent purchase price liabilities3$(19,679)$(40,248)

During the nine months ended September 30, 2026 and 2025, there were no transfers between the valuation hierarchy Levels 1, 2, and 3. The Company reclassified itsavailable-for-sale debt securities from Level 1 to Level 2 as these securities are not traded on an exchange as of September 30, 2026 and December 31, 2025.

The following table summarizes the change in Level 3 fair values of our contingent purchase price liabilities for the nine months ended September 30, 2026 and 2025(pre-tax basis, in thousands):

20262025
Beginning balance – December 31$(40,248)$(96,967)
Additions from business acquisitions(1,835)(2,941)
Settlement of contingent purchase price liabilities19,76660,635
Change in fair value of contingencies3,440170
Change in net present value of contingencies(802)(2,154)
Ending balance – September 30$(19,679)$(41,257)

The following table summarizes the changes in contingent purchase price consideration for previous acquisitions and contingent payments made for previous business acquisitions in the three and nine months ended September 30, 2026 and 2025, respectively (in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Net (income) expense$(1,060)$497$(2,638)$1,984
Cash settlement paid$334$7,061$18,545$55,825
Shares issued (number)—133660

Refer to Note 8, Fair Value Measurements, to the consolidated financial statements contained in our Annual Report on Form

10-K

for the year ended December 31, 2025, as amended, for further discussion on the fair value measurements and classification of our financial assets and

liabilities

.

NOTE 9. OTHER COMPREHENSIVE INCOME

The following table is a summary of other comprehensive income (loss) and discloses the tax impact of each component of other comprehensive income (loss) for the three and nine months ended September 30, 2026 and 2025 (in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Net unrealized (loss) gain on available-for-sale securities, net of taxes(1)$(419)$35$(764)$158
Net unrealized gain (loss) on interest rate swaps, net of taxes(2)4,838(1,271)9,171(4,736)
Foreign currency translation(128)(6)(126)(14)
Total other comprehensive income (loss), net of tax$4,291$(1,242)$8,281$(4,592)
(1)Net of income tax benefit of $166 and income tax expense of $12 for the three months ended September 30, 2026 and 2025, respectively. Net of income tax expense of $304 and $63 for the nine months ended September 30, 2026 and 2025, respectively.
(2)Net of income tax expense of $1,615 and income tax benefit of $422 for the three months ended September 30, 2026 and 2025, respectively. Net of income tax expense of $2,892 and income tax benefit of $1,578 for the nine months ended September 30, 2026 and 2025, respectively.

NOTE 10. COMMON STOCK

Common Stock Issued for the Marcum Transaction - Pursuant to the Marcum Merger Agreement and as part of the total purchase price consideration, we issued shares of our common stock to the selling shareholders in the Marcum Transaction. Refer to Note 3, Business Combinations, for more detail.

Right of First Refusal Program - Pursuant to the Marcum Merger Agreement, the Company and selling shareholders entered into a Right of First Refusal Agreement (the “ROFR Agreement”). Under the ROFR Agreement, the selling shareholders granted the Company a right of first refusal to repurchase all or any portion of our common stock issued to the selling shareholders pursuant to the Marcum Merger Agreement. The Company holds the right of first refusal until November 1, 2028.

Share Repurchase Program - Over the past twenty years, our Board of Directors has annually renewed the Company’s Share Repurchase Program. On February 11, 2025, the Board of Directors renewed and authorized the Share Repurchase Program, permitting repurchases through March 31, 2026, of up to 5.0 million shares of our outstanding common stock (i) in the open market, (ii) in privately negotiated transactions, or (iii) under Rule 10b5-1 trading plans. On February 11, 2026, our Board of Directors authorized the continuation of the Share Repurchase Program. The continuation of the Share Repurchase Program was effective beginning on February 11, 2026 at which time the amount of shares of common stock available to be purchased by the Company was reset to 5 million shares. The Share Repurchase Program expires on March 31, 2027.

Privately negotiated transactions may include repurchases from employees, officers and directors and repurchases from former partners of Marcum pursuant to the ROFR Agreement, as discussed above.

Refer to Note 14, Common Stock, to the consolidated financial statements contained in our Annual Report on Form

10-K

for the year ended December 31, 2025, as amended, for more detail about the Share Repurchase Program.

We repurchased 0.2 million shares of our common stock for a total cost of $7.5 million under the ROFR Agreement

, $0.1 million shares of our common stock for a total cost of $7.3 million under a rescission offer,

and

2.1

million shares of our common stock in the open market for $

60.1

million during the nine months ended September 30, 2026. During the nine months ended September 30, 2025, we repurchased

1.4

million shares of our common stock for a cost of $

102.8

million under the ROFR Agreement and

0.4

million share repurchases from the open market for $

25.0

million dollars.

Additionally, to settle statutory employee withholdings related to vesting of stock awards, we repurchased

0.1

million shares of our common stock at a cost of $

3.0

million during the nine months ended September 30, 2026 and

0.1

million shares at a cost of $

7.8

million during the nine months ended September 30, 2025.

NOTE 11. EMPLOYEE STOCK PLANS

We granted various stock-based awards under the CBIZ, Inc. 2019 Stock Omnibus Incentive Plan, as amended (the “2019 Plan”). The 2019 Plan, which expires in 2029, permits a maximum of 4.6 million stock options, restricted stock or other stock-based compensation awards to be granted. The terms and vesting schedules for the stock-based awards vary by type and date of grant. Shares subject to award under the 2019 Plan may be either authorized but unissued shares of our common stock or treasury shares. Refer to Note 15, Employee Stock Plans to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2025, asamended, for further discussion on the 2019 Plan and descriptions of the types of stock-based awards.

Compensation expense for stock-based awards recognized during the three and nine months ended September 30, 2026 and 2025 was as follows (in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Restricted stock units and awards$5,977$5,134$18,729$15,282
Performance share units5462,2003,4294,291
Total stock-based compensation expense$6,523$7,334$22,158$19,573

Stock Options and Restricted Stock Units and Awards – The Company didnot grant any stock options during the nine months ended September 30, 2026.50 thousand stock options were exercised at a weighted average exercise price of $24.62 during the three months ended September 30, 2026. As of September 30, 2026, we have 100 thousand stock options outstanding with a weighted average exercise price per share of $40.52.

For the nine months ended September 30, 2026, the Company granted a total of 698 thousand Restricted Stock Units (“RSU”) to certain employees, of which 324 thousand RSUs vest on the third anniversary of the grant date,99 thousand RSUs vest on the second anniversary of the grant date, and 275 thousand RSUs vest evenly over three years. Additionally,42 thousand Restricted Stock Awards (“RSA”) were granted tonon-employee directors.

The following table presents our restricted stock units and awards activity during the nine months ended September 30, 2026 (in thousands, except per share unit data):

Restricted Stock Units and Awards
Number of SharesWeighted Average Grant-Date Fair Value (1)
Outstanding at beginning of year911$70.36
Granted740$28.20
Exercised or released(120)$69.66
Expired or canceled(26)$41.07
Outstanding at September 30, 20261,505$50.18
(1)Represents weighted average market value of the shares; awards are granted at no cost to the recipients.

Performance Share Units (“PSUs”) –

PSUs are earned based on our financial performance over a contractual term ofthree years and the associated expense is recognized over that period based on the fair value of the award. Athree-year cliff vesting schedule of the PSUs is dependent upon the Company’s performance measured against

pre-established

goals which are mainly based on a

weighted

combination of an earnings per share target and a total growth in revenue target or relative total shareholder return target. The fair value of PSUs is calculated using the market value of a share of our common stock on the date of grant. For performance achieved above specified levels, the recipient may earn additional shares of stock, not to exceed 200% of the number of PSUs initially granted, except for the PSUs granted in 2025 that shall not exceed 300%.

The following table presents our PSUs activity during the nine

months

ended September 30, 2026 (in thousands, except per share unit data):

Performance Share UnitsWeighted Average Grant-Date Fair Value Per Unit (1)
Outstanding at beginning of year253$64.83
Granted256$28.33
Vested(102)$48.40
Canceled(15)$48.16
Outstanding at September 30, 2026392$45.89
(1)Represents weighted average market value of the PSUs; PSUs are granted at no cost to the recipients.

NOTE 12. EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2026 and 2025 (in thousands, except per share data):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Numerator:
Net income$36,771$30,146$208,162$194,861
Denominator:
Basic
Weighted average common shares outstanding59,26462,36060,05763,243
Diluted
Stock options (1)29682377
Restricted stock units and awards (1)602152162170
Performance share units9111691116
Contingent shares (2)—3—3
Diluted weighted average common shares outstanding (3)59,98662,69960,33363,609
Basic earnings per share$0.62$0.48$3.47$3.08
Diluted earnings per share$0.61$0.48$3.45$3.06
(1)A total of 48 thousand and 789 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2026, respectively, as their effect would be anti-dilutive. A total of 103 thousand and 73 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2025, respectively, as their effect would be anti-dilutive.
(2)Contingent shares represent additional shares to be issued for purchase price earned by former owners of businesses acquired by us once future conditions have been met.
(3)The denominator used in calculating diluted earnings per share did not include 301 thousand PSUs for the three and nine months ended September 30, 2026. The denominator used in calculating diluted earnings per share did not include 151 thousand PSUs for the three and nine months ended September 30, 2025. The performance conditions associated with these PSUs were not met and consequently none of these PSUs were considered as issuable for the three and nine months ended September 30, 2026 and 2025.

NOTE 13. GOODWILL

During the first quarter of 2026, we completed certain organizational changes which resulted in a change to our presentation of reportable segments. The National Practice group, which consisted of a single reporting unit, is now included in the Financial Services practice group to align the internal management and reporting structure with the services provided by the practice groups. As of February 28, 2026, immediately afterthe organizational changes, there are a total offive reporting units, of which three are within the Financial Services practice group andtwo are within the Benefits and Insurances practice group.

As a result of the aforementioned changes in reporting units, we performed a qualitative assessment immediately before the change in reporting units as it relates to thetwo reporting units impacted by the change. We concluded that it was more likely than not that the fair values of these reporting units immediately before the change exceeded their respective carrying values and, therefore, goodwill related to those reporting units immediately before the change was determined tonot be impaired.

The change in reporting units is considered a triggering event. We performed a quantitative assessme

nt im

mediately after the change in reporting units by comparing the fair values of the reporting units to their respective carrying values. In measuring the estimated fair value of each reporting unit, we utilized a combination of an income approach and a market approach. Under the income approach, a discounted cash flow analysis is performed with estimates based on forecasted and projected operating cash flows, with significant assumptions related to revenue growth rates, profitability margins, and discount rates, which all vary among reporting units. The market approach utilizes the guideline public company method and is based on revenue and earnings multiple data derived from publicly traded peer group companies. Based on the results of the quantitative assessment, we concluded that the estimated fair values of our reporting units immediately after the change were in excess of their respective carrying values, and goodwill was not impaired.

During the first quarter of 2026, we experienced a decline in the Company’s market capitalization. This decline, along with increases in discount rates used in the aforementioned quantitative impairment analysis, reduced the excess of fair value over carrying value of our Financial Accounting Services reporting unit within the Financial Services practice group and our Property and Casualty reporting unit within our Benefits and Insurance Services practice group as of March 31, 2026. During the second quarter of 2026, the Company’s market capitalization improved, and we performed a qualitative assessment of its goodwill and concluded that it was more likely than not the fair values of the Company’s reporting units exceeded their respective carrying value, and therefore, goodwill related to the Company’s reporting units was determined to not be impaired. During the third quarter of 2026, the Company monitored internal and external macro factors and concluded that no goodwill impairment triggering events occurred. Accordingly, no interim qualitative or quantitative goodwill impairment testing was required, andno goodwill impairment losses were recognized during the three and nine months ended September 30, 2026.

It is possible, depending upon a number of factors that are not determinable at this time or within our control, that the fair value of one or more of our reporting units could decrease in the future, which could result in an impairment to goodwill. Such factors include failure to achieve the anticipated benefits of the Marcum Transaction, significant negative industry or economic trends, disruptions to our business, adverse changes resulting from new governmental regulations, negative impact on client list due to loss of customers, impact on client list due to declining revenue of existing customers, or divestitures. Additionally, declines in our market capitalization may result in the need for impairment assessments in the future, which could result in the recognition of an impairment charge. Further, any significant adverse change in our near or long-term projections or macroeconomic conditions could result in future impairment charges, which could be material.

A summary of changes in the carrying amount of goodwill by operating segment for the nine months ended September 30, 2026 is as follows (in thousands):

Financial ServicesBenefits and Insurance ServicesNational PracticeTotal
Gross Goodwill at December 31, 2025$2,039,675$340,238$33,873$2,413,786
Accumulated impairment(44,047)(7,733)(32,207)(83,987)
Goodwill, Net at December 31, 20251,995,628332,5051,6662,329,799
Additions11,470——11,470
Foreign Currency Translation(96)——(96)
Transfer - Gross goodwill(1)33,873—(33,873)—
Transfer - Accumulated impairment(1)(32,207)—32,207—
Gross Goodwill at September 30, 20262,084,922340,238—2,425,160
Accumulated impairment(76,254)(7,733)—(83,987)
Goodwill, Net at September 30, 2026$2,008,668$332,505$—$2,341,173
(1)Reflects change in reporting units which is the transfer of the reporting unit previously included under the National Practice segment to the Financial Services segment during the nine months ended September 30, 2026.

NOTE 14. SEGMENT DISCLOSURES

As discussed in Note 13. Goodwill, the National Practices reportable segment, which consisted of a single reporting unit, was combined with a reporting unit included in the Financial Services practice group to better align our current internal management information reviewed by Chief Operating Decision Maker and reporting structure with the services provided. As a result of these changes, we now operate withtwo reportable segments: Financial Services and Benefits and Insurances Services. Financial results of the Financial Service Practice Group for the three and nine months ended September 30, 2025 were adjusted to reflect the change in reportable segments.

Corporate and Other -Included in Corporate and Other are operating expenses that are not directly allocatedto the individual business units. These expenses primarily consist of certain health care costs, gains or losses attributable to assets held in ournon-qualified deferred compensation plan, stock-based compensation, consolidation and integration charges, certain professional fees, certain advertising costs, and other various expenses.

Accounting policies of the practice groups are the same as those described in Note 1, Basis of Presentation and Significant Accounting Policies, to the Annual Report on Form 10-K for the year ended December 31, 2025, as amended. Upon consolidation, intercompany accounts and transactions are eliminated, thus inter-segment revenue is not included in the measure of profit or loss for the practice groups. Performance of the practice groups is evaluated on income (loss) before income tax expense (benefit) excluding those costs listed above, which are reported in “Corporate and Other.”

The practice groups respective revenue andpre-tax income, significant segment expenses, and a reconciliation of segment profit or loss measure to the consolidated income before income tax expense for the three and nine months ended September 30, 2026 and 2025 is presented below. The segment profit or loss measure for the three and nine months ended September 30, 2025 has been restated and reflects the currenttwo reportable segments. We do not manage our assets on a segment basis, therefore segment assets are not presented below.

Segment information for the three months ended September 30, 2026 and 2025 was as follows (in thousands):

Financial ServicesBenefits and Insurance ServicesTotal
Revenue from external customers$597,791$104,449$702,240
Significant expenses:
Personnel costs369,85266,285436,137
Facility costs22,4033,00225,405
Other costs, gains, and losses, net (1)95,21316,667111,880
Total segment expense487,46885,954573,422
Segment income before income tax expense110,32318,495128,818
Corporate & other:
Unallocated corporate operating expenses14,176
General & administrative expenses38,518
Interest expense23,975
Other expense, net(850)
Consolidated income before income tax expense$52,999
Financial ServicesBenefits and Insurance ServicesTotal
Revenue from external customers$590,431$103,387$693,818
Significant expenses:
Personnel costs391,66665,222456,888
Facility costs22,9393,21926,158
Other costs, gains, and losses, net (1)79,41615,59995,015
Total segment expense494,02184,040578,061
Segment income before income tax expense96,41019,347115,757
Corporate & other:
Unallocated corporate operating expenses25,081
General & administrative expenses31,265
Interest expense27,960
Other expense, net(8,955)
Consolidated income before income tax expense$40,406
Financial ServicesBenefits and Insurance ServicesTotal
Revenue from external customers$1,918,445$314,580$2,233,025
Significant expenses:
Personnel costs1,157,282196,3071,353,589
Facility costs72,4159,43381,848
Other costs, gains, and losses, net (1)289,34151,307340,648
Total segment expense1,519,038257,0471,776,085
Segment income before income tax expense399,40757,533456,940
Corporate & other:
Unallocated corporate operating expenses44,395
General & administrative expenses118,395
Interest expense72,199
Gain from acquisition related adjustment(57,955)
Other income, net(11,308)
Consolidated income before income tax expense$291,214
Financial ServicesBenefits and Insurance ServicesTotal
Revenue from external customers$1,897,036$318,292$2,215,328
Significant expenses:
Personnel costs1,201,748196,9651,398,713
Facility costs70,2909,62279,912
Other costs, gains, and losses, net (1)237,52146,445283,966
Total segment expense1,509,559253,0321,762,591
Segment income before income tax expense387,47765,260452,737
Corporate & other:
Unallocated corporate operating expenses45,518
General & administrative expenses86,972
Interest expense80,983
Other income, net(31,831)
Consolidated income before income tax expense$271,095
(1)Other costs, gains, and losses, net primarily consist of travel and entertainment costs, computer and technology related costs, depreciation and amortization expenses, and other discretionary costs.

NOTE 15. SUBSEQUENT EVENTS

On October 27, 2026, the Company held a virtual special meeting of stockholders (the “Special Meeting”). At the Special Meeting, among other matters, the proposal to adopt the Merger Agreement was approved, having received “for” votes from holders of a majority of the outstanding shares entitled to vote on the Merger Agreement proposal.

The Company expects to close the proposed Merger on or about November 2, 2026, in accordance with, and subject to the terms of, the Merger Agreement.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.